{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADMET", "QSAR", "breast cancer", "molecular docking", "withanolides"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28694686", "DateCompleted": {"Year": "2018", "Month": "04", "Day": "18"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "06", "Day": "22"}], "Language": ["eng"], "ELocationID": ["10.2147/DDDT.S130601"], "Journal": {"ISSN": "1177-8881", "JournalIssue": {"Volume": "11", "PubDate": {"Year": "2017"}}, "Title": "Drug design, development and therapy", "ISOAbbreviation": "Drug Des Devel Ther"}, "ArticleTitle": "Molecular docking, QSAR and ADMET studies of withanolide analogs against breast cancer.", "Pagination": {"StartPage": "1859", "EndPage": "1870", "MedlinePgn": "1859-1870"}, "Abstract": {"AbstractText": ["Withanolides are a group of pharmacologically active compounds present in most prodigal amounts in roots and leaves of <i>Withania somnifera</i> (Indian ginseng), one of the most important medicinal plants of Indian traditional practice of medicine. Withanolides are steroidal lactones (highly oxygenated C-28 phytochemicals) and have been reported to exhibit immunomodulatory, anticancer and other activities. In the present study, a quantitative structure activity relationship (QSAR) model was developed by a forward stepwise multiple linear regression method to predict the activity of withanolide analogs against human breast cancer. The most effective QSAR model for anticancer activity against the SK-Br-3 cell showed the best correlation with activity (<i>r</i><sup>2</sup>=0.93 and rCV<sup>2</sup> =0.90). Similarly, cross-validation regression coefficient (rCV<sup>2</sup>=0.85) of the best QSAR model against the MCF7/BUS cells showed a high correlation (<i>r</i><sup>2</sup>=0.91). In particular, compounds CID_73621, CID_435144, CID_301751 and CID_3372729 have a marked antiproliferative activity against the MCF7/BUS cells, while 2,3-dihydrowithaferin A-3-beta-<i>O</i>-sulfate, withanolide 5, withanolide A, withaferin A, CID_10413139, CID_11294368, CID_53477765, CID_135887, CID_301751 and CID_3372729 have a high activity against the Sk-Br-3 cells compared to standard drugs 5-fluorouracil (5-FU) and camptothecin. Molecular docking was performed to study the binding conformations and different bonding behaviors, in order to reveal the plausible mechanism of action behind higher accumulation of active withanolide analogs with \u03b2-tubulin. The results of the present study may help in the designing of lead compound with improved activity."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, College of Pharmacy, Gachon University, Yeonsu-gu, Incheon, Republic of Korea."}], "LastName": "Yadav", "ForeName": "Dharmendra K", "Initials": "DK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Babu Banarasi Das Northern India Institute of Technology, Lucknow."}], "LastName": "Kumar", "ForeName": "Surendra", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, College of Pharmacy, Gachon University, Yeonsu-gu, Incheon, Republic of Korea."}], "LastName": "Saloni"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioinformatics, Indian Council of Medical Research, New Delhi."}], "LastName": "Singh", "ForeName": "Harpreet", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, College of Pharmacy, Gachon University, Yeonsu-gu, Incheon, Republic of Korea."}], "LastName": "Kim", "ForeName": "Mi-Hyun", "Initials": "MH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur."}], "LastName": "Sharma", "ForeName": "Praveen", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur."}], "LastName": "Misra", "ForeName": "Sanjeev", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic & Structural Biology Department, CSIR-Central Institute of Medicinal & Aromatic Plant, Lucknow, India."}], "LastName": "Khan", "ForeName": "Feroz", "Initials": "F"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Drug Des Devel Ther", "NlmUniqueID": "101475745", "ISSNLinking": "1177-8881"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antimetabolites, Antineoplastic"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Withanolides"}, {"RegistryNumber": "U3P01618RT", "NameOfSubstance": "Fluorouracil"}, {"RegistryNumber": "XT3Z54Z28A", "NameOfSubstance": "Camptothecin"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antimetabolites, Antineoplastic"}, {"QualifierName": ["chemistry", "pharmacokinetics", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Camptothecin"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Fluorouracil"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "MCF-7 Cells"}, {"QualifierName": [], "DescriptorName": "Models, Chemical"}, {"QualifierName": [], "DescriptorName": "Molecular Conformation"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Quantitative Structure-Activity Relationship"}, {"QualifierName": [], "DescriptorName": "Reproducibility of Results"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tubulin"}, {"QualifierName": ["chemistry", "pharmacokinetics", "pharmacology"], "DescriptorName": "Withanolides"}], "CoiStatement": "Disclosure The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Qurishi Y, Hamid A, Majeed R, et al. Interaction of natural products with cell survival and signaling pathways in the biochemical elucidation of drug targets in cancer. Future Oncol. 2011;7(8):1007\u20131021.", "ArticleIdList": ["21823895"]}, {"Citation": "Ali R, Mirza Z, Ashraf GM, et al. New anticancer agents: recent developments in tumor therapy. Anticancer Res. 2012;32(7):2999\u20133005.", "ArticleIdList": ["22753764"]}, {"Citation": "Mirjalili MH, Moyano E, Bonfill M, Cusido RM, Palaz\u00f3n J. Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecules. 2009;14(7):2373\u20132393.", "ArticleIdList": ["PMC6255378", "19633611"]}, {"Citation": "Vanden Berghe W, Sabbe L, Kaileh M, Haegeman G, Heyninck K. Molecular insight in the multifunctional activities of Withaferin A. Biochem Pharmacol. 2012;84(10):1282\u20131291.", "ArticleIdList": ["22981382"]}, {"Citation": "Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev. 2000;5(4):334\u2013346.", "ArticleIdList": ["10956379"]}, {"Citation": "Misra L, Mishra P, Pandey A, Sangwan RS, Sangwan NS, Tuli R. Withanolides from Withania somnifera roots. Phytochemistry. 2008;69(4):1000\u20131004.", "ArticleIdList": ["18061221"]}, {"Citation": "Chaurasiya ND, Uniyal GC, Lal P, et al. Analysis of withanolides in root and leaf of Withania somnifera by HPLC with photodiode array and evaporative light scattering detection. Phytochem Anal. 2008;19(2):148\u2013154.", "ArticleIdList": ["17879227"]}, {"Citation": "Widodo N, Kaur K, Shrestha BG, et al. Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect. Clin Cancer Res. 2007;13(7):2298\u20132306.", "ArticleIdList": ["17404115"]}, {"Citation": "Padmavathi B, Rath PC, Rao AR, Singh RP. Roots of Withania somnifera inhibit forestomach and skin carcinogenesis in mice. Evid Based Complement Alternat Med. 2005;2(1):99\u2013105.", "ArticleIdList": ["PMC1062157", "15841284"]}, {"Citation": "Devi PU, Sharada AC, Solomon FE. Antitumor and radiosensitizing effects of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, Sarcoma-180. Indian J Exp Biol. 1993;31(7):607\u2013611.", "ArticleIdList": ["8225418"]}, {"Citation": "Kumar P, Kushwaha RA. Medicinal evaluation of Withania somnifera (L.) Dunal (Ashwagandha) Asian J Chem. 2006;18(2):1401\u20131404."}, {"Citation": "Sharada AC, Solomon FE, Devi PU. Toxicity of Withania somnifera root extract in rats and mice. Int J Pharm. 1993;31(3):205\u2013212."}, {"Citation": "Kupchan SM, Anderson WK, Bollinger P, et al. Tumor inhibitors. XXXIX. Active principles of Acnistus arborescens. Isolation and structural and spectral studies of withaferin A and withacnistin. J Org Chem. 1969;34(12):3858\u20133866.", "ArticleIdList": ["5357526"]}, {"Citation": "Shohat B, Gitter S, Abraham A, Lavie D. Antitumor activity of withaferin A (NSC-101088) Cancer Chemother Rep. 1967;51:271\u2013276.", "ArticleIdList": ["6062297"]}, {"Citation": "Jayaprakasam B, Zhang Y, Seeram NP, Nair MG. Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves. Life Sci. 2003;74(1):125\u2013132.", "ArticleIdList": ["14575818"]}, {"Citation": "al-Hindawi MK, al-Khafaji SH, Abdul-Nabi MH. Anti-granuloma activity of Iraqi Withania somnifera. J Ethnopharmacol. 1992;37(2):113\u2013116.", "ArticleIdList": ["1434685"]}, {"Citation": "Shohat B, Kirson I, Lavie D. Immunosuppressive activity of two plant steroidal lactones withaferin A and withanolide E. Biomedicine. 1978;28(1):18\u201324.", "ArticleIdList": ["27256"]}, {"Citation": "Wang HC, Tsai YL, Wu YC, et al. Withanolides-induced breast cancer cell death is correlated with their ability to inhibit heat protein 90. PLoS One. 2012;7(5):e37764.", "ArticleIdList": ["PMC3365124", "22701533"]}, {"Citation": "Hahm ER, Lee J, Kim SH, et al. Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model. J Natl Cancer Inst. 2013;105(15):1111\u20131122.", "ArticleIdList": ["PMC3735460", "23821767"]}, {"Citation": "Hahm ER, Moura MB, Kelley EE, Van Houten B, Shiva S, Singh SV. Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species. PLoS One. 2011;6(8):e23354.", "ArticleIdList": ["PMC3154436", "21853114"]}, {"Citation": "Stan SD, Hahm ER, Warin R, Singh SV. Withaferin A causes FOXO3a-and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Cancer Res. 2008;68(18):7661\u20137669.", "ArticleIdList": ["PMC2562581", "18794155"]}, {"Citation": "Lee J, Hahm ER, Singh SV. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells. Carcinogenesis. 2010;31(11):1991\u20131998.", "ArticleIdList": ["PMC2966554", "20724373"]}, {"Citation": "Lee J, Sehrawat A, Singh SV. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells. Breast Cancer Res Treat. 2012;136(1):45\u201356.", "ArticleIdList": ["PMC3474857", "22965833"]}, {"Citation": "Dwivedi GR, Maurya A, Yadav DK, Khan F, Darokar MP, Srivastava SK. Drug resistance reversal potential of ursolic acid derivatives against nalidixic acid- and multidrug-resistant Escherichia coli. Chem Biol Drug Des. 2015;86(3):272\u2013283.", "ArticleIdList": ["25476148"]}, {"Citation": "Gaur R, Yadav DK, Kumar S, Darokar MP, Khan F, Bhakuni RS. Molecular modeling based synthesis and evaluation of in vitro anticancer activity of indolyl chalcones. Curr Top Med Chem. 2015;15(11):1003\u20131012.", "ArticleIdList": ["25860176"]}, {"Citation": "Yadav DK, Rai R, Kumar N, et al. New arylated benzo[h]quinolines induce anti-cancer activity by oxidative stress-mediated DNA damage. Sci Rep. 2016;6:38128.", "ArticleIdList": ["PMC5138627", "27922047"]}, {"Citation": "Attri P, Kumar N, Park JH, et al. Influence of reactive species on the modification of biomolecules generated from the soft plasma. Sci Rep. 2015;5:8221.", "ArticleIdList": ["PMC4316168", "25649786"]}, {"Citation": "Machin RP, Veleiro AS, Nicotra VE, Oberti JC, M Padr\u00f3n J. Anti-proliferative activity of withanolides against human breast cancer cell lines. J Nat Prod. 2010;73(5):966\u2013968.", "ArticleIdList": ["20438092"]}, {"Citation": "Yadav DK, Dhawan S, Chauhan A, et al. QSAR and docking based semi-synthesis and in vivo evaluation of artemisinin derivatives for antimalarial activity. Curr Drug Targets. 2014;15(8):753\u2013761.", "ArticleIdList": ["24975562"]}, {"Citation": "Yadav DK, Kalani K, Singh AK, Khan F, Srivastava SK, Pant AB. Design, synthesis and in vitro evaluation of 18\u03b2-glycyrrhetinic acid derivatives for anticancer activity against human breast cancer cell line MCF-7. Curr Med Chem. 2014;21(9):1160\u20131170.", "ArticleIdList": ["24180274"]}, {"Citation": "Yadav DK, Ahmad I, Shukla A, Khan F, Negi AS, Gupta A. QSAR and docking studies on chalcone derivatives for antitubercular activity against M. tuberculosis H37Rv. J Chemom. 2014;28:499\u2013507."}, {"Citation": "Antony ML, Lee J, Hahm ER, et al. Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of \u03b2-tubulin. J Biol Chem. 2014;289(3):1852\u20131865.", "ArticleIdList": ["PMC3894360", "24297176"]}, {"Citation": "Yadav DK, Khan F. QSAR, docking and ADMET studies of camptothecin derivatives as inhibitors of DNA topoisomerase-I. J Chemom. 2013;27:21\u201333."}, {"Citation": "Yadav DK, Mudgal V, Agrawal J, et al. Molecular docking and ADME studies of natural compounds of Agarwood oil for topical anti-inflammatory activity. Curr Comput Aided Drug Des. 2013;9(3):360\u2013370.", "ArticleIdList": ["23566359"]}, {"Citation": "Yadav DK, Kalani K, Khan F, Srivastava SK. QSAR and docking based semi-synthesis and in vitro evaluation of 18\u03b2-glycyrrhetinic acid derivatives against human lung cancer cell line A-549. Med Chem. 2013;9(8):1073\u20131084.", "ArticleIdList": ["23675978"]}, {"Citation": "QikProp . QikProp version 3.2. New York, NY: Schr\u00f6dinger, LLC; 2013."}, {"Citation": "Yadav DK, Khan F, Negi AS. Pharmacophore modeling, molecular docking, QSAR, and in silico ADMET studies of gallic acid derivatives for immunomodulatory activity. J Mol Model. 2012;18(6):2513\u20132525.", "ArticleIdList": ["22038459"]}, {"Citation": "Yadav DK, Meena A, Srivastava A, Chanda D, Khan F, Chattopadhyay SK. Development of QSAR model for immunomodulatory activity of natural coumarinolignoids. Drug Des Devel Ther. 2010;4:173\u2013186.", "ArticleIdList": ["PMC2939762", "20856844"]}, {"Citation": "Kumar S, Tiwari M. Grid potential analysis, virtual screening studies and ADME/T profiling on N-arylsulfonylindoles as anti-HIV-1 agents. J Chemom. 2013;27(6):143\u2013154."}]}], "History": [{"Year": "2017", "Month": "7", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "4", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["28694686", "PMC5491705", "10.2147/DDDT.S130601", "dddt-11-1859"]}}]}